Last week I sent an email to admin just seeking confirmation that TGA approval hadn't been applied for yet. At first I was disappointed I didn't receive a reply, and then yesterday looking for an email in my junk folder for a gift certificate my daughter said she had ordered for me, there was an email from Camile.
He confirmed what I suspected..
"...other regulatory approvals including Australian TGA will be sought following FDA approval. There are benefits to following this path, which we hope to maximise for the company. Once FDA approval is granted, we will make an ASX announcement in due course, and then will update the market on next steps."
That got me curious on the timeline and the priority of 'other markets'. I assume it will be a distributor model. Will the same distributors as with the Five2 be used - simply put another product in the kitbag. They in my view haven't been too successful in their respective markets so far. Could an inhouse sales team be a better way for Invivage? Which markets would be a good focus. Obviously the US market is the where 80% of the marketing for 6 months after FDA, but where to from there?
Add to My Watchlist
What is My Watchlist?
